Cargando…

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy

The tumor microenvironment is a key determinant of cancer cell biology. The microenvironment is a complex mixture of tumor cells, stromal cells, and proteins, extracellular matrix, oxygen tension, and pH levels surrounding the cells that regulate the tumor progress. This study identified the prognos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hai‐Long, OuYang, Han‐Yue, Le, Yong, Jiang, Peng, Tang, Hui, Yu, Zi‐Shan, He, Min‐Ke, Tang, Yun‐Qiang, Shi, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246944/ https://www.ncbi.nlm.nih.gov/pubmed/30306706 http://dx.doi.org/10.1002/cam4.1521

Ejemplares similares

The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma
por: Kim, Sewha, et al.
Publicado: (2013)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021)

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy
por: Wang, Haoyuan, et al.
Publicado: (2014)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma
por: Liu, Jian, et al.
Publicado: (2016)

Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth
por: Contat, Caroline, et al.
Publicado: (2020)

Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy
por: Wang, Yan-Yan, et al.
Publicado: (2014)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

Long non-coding RNA FTX predicts a poor prognosis of human cancers: a meta-analysis
por: Chen, Weiwei, et al.
Publicado: (2021)

Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma
por: Liu, Yannan, et al.
Publicado: (2019)

High lncSNHG15 expression may predict poor cancer prognosis: a meta-analysis based on the PRISMA and the bio-informatics analysis
por: Fang, Shi Xu, et al.
Publicado: (2020)

Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy
por: Chen, Jian-yao, et al.
Publicado: (2017)

Pulmonary function impairment predicted poor prognosis of patients with hepatocellular carcinoma after hepatectomy
por: Zhao, Yanhua, et al.
Publicado: (2017)

High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer
por: Tong, Ying-Hui, et al.
Publicado: (2021)

Tumor burden score dictates prognosis of patients with combined hepatocellular cholangiocarcinoma undergoing hepatectomy
por: Deng, Gang, et al.
Publicado: (2023)

Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma
por: Long, Yaping, et al.
Publicado: (2018)

Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy
por: Guo, XiaoDong, et al.
Publicado: (2014)

Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4
por: Rademakers, Saskia E, et al.
Publicado: (2011)

Efficacy and prognostic factors of repeated hepatectomy for postoperative intrahepatic recurrence of hepatocellular carcinoma undergoing initial hepatectomy
por: Cen, Feng, et al.
Publicado: (2023)

Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma
por: Iida, Noriho, et al.
Publicado: (2019)

Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer
por: Choi, Stephen Yiu Chuen, et al.
Publicado: (2018)

Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022)

A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy
por: Liang, Jie‐ying, et al.
Publicado: (2021)

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma
por: Sun, Hong-Wei, et al.
Publicado: (2016)

Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy
por: Chen, Jen-Lung, et al.
Publicado: (2023)

An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma
por: Chen, Dayang, et al.
Publicado: (2021)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020)

Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2011)

PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer
por: Zhang, Min, et al.
Publicado: (2020)

Treatment of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma
por: Matsumoto, Michinori, et al.
Publicado: (2021)

High expression of TOP2A gene predicted poor prognosis of hepatocellular carcinoma after radical hepatectomy
por: Cai, Hongyu, et al.
Publicado: (2020)

Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy
por: Sun, Li-Yue, et al.
Publicado: (2022)

Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
por: Dell’Anno, Irene, et al.
Publicado: (2020)

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma
por: Okabe, Hirohisa, et al.
Publicado: (2018)

Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy
por: Li, Chuan, et al.
Publicado: (2020)

Parenchymal‐sparing versus extended hepatectomy for colorectal liver metastases: A systematic review and meta‐analysis
por: Deng, Gang, et al.
Publicado: (2019)

A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma
por: Stewart, Paul A., et al.
Publicado: (2015)

Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy
por: Liao, Rui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g595v1td7f282din5deg1nlhto